Microvast Faces Nasdaq Deadline as Cash Crunch and Demand Slump Collide

Microvast Holdings has a compliance clock ticking alongside its liquidity problems. According to the quarterly report filed Monday, the Nasdaq has given the battery maker until February 22, 2027 to regain compliance with the minimum bid price requirement — a second front opening just as the company battles to keep its finances afloat.

Investors reacted sharply. The stock was down 6.5% at one point, and the sell-off deepened to a 9.4% loss after the liquidity warning published the same day triggered the heavy selling that followed the earnings release.

Demand Collapse Hits the Top Line

The operational backdrop is grim. Revenue for the third quarter of 2026 fell 62.8% to $45.8 million. Sales volume came in at roughly 189.6 MWh, a 62.2% decline year over year, which management attributed to weaker commercial vehicle demand in Europe and the Asia-Pacific region.

Profitability has eroded just as dramatically. The gross margin stood at 5.2%, down from 37.6% in the comparable 2025 quarter. Microvast also booked a $9.3 million inventory write-down. Management acknowledged that the operational downturn has significantly constrained liquidity.

Twelve Months of Runway in Question

As of October 31, Microvast reported usable liquid funds of approximately $71.3 million. Without additional measures, the company expected available resources would not be enough to meet its obligations over the following twelve months. The conditions for closing that gap, per the company: fresh capital, refinancing or extension of debt, and substantial further cost cuts. Material doubt about its ability to continue as a going concern remains unresolved, Microvast said.

The company announced Monday that it will cut operating costs and reduce headcount in a targeted manner, while scaling back or deferring discretionary capital expenditures. Those steps are tied to the uncertain liquidity position, ongoing talks with lenders, and weaker end demand.

Cost discipline can lower expenses, but its effect on financial stability also depends on what the remaining business earns. A higher sales volume would be especially valuable if profitability recovers at the same time. As long as the margin stays low, the ability to generate financial headroom from operations remains under pressure.

Cantor Trims Target, Keeps Bullish Stance

Cantor Fitzgerald lowered its price target on Microvast from $5 to $2 on Tuesday, according to media reports, while maintaining its "Overweight" rating. The firm thus paired a sharply reduced target with a continued positive view of the stock.

For investors, the durability of any recovery hinges on three interlocking pieces: demand, margin, and financing. Progress should be measured against that combination.